microRNA-6788 (MIR6788)

**microRNA-6788 (MIR6788)** is a predicted microRNA in the human genome. MicroRNAs are short (~22 nucleotide) non-coding RNAs that regulate gene expression by binding to complementary target mRNAs, leading to mRNA cleavage or translational repression[5][3]. The canonical biogenesis of microRNAs includes transcription by RNA polymerase II, processing by DGCR8 and Drosha to pre-miRNA, export to the cytoplasm, and further processing by Dicer before incorporation into the RNA-induced silencing complex (RISC)[1][5]. The specific functions and disease roles of MIR6788 are currently not described in the scientific literature, and it is not recognized as a validated therapeutic target or biomarker. **Critical Notes:** - There is **no evidence that microRNA-6788 (MIR6788) is a validated or commonly studied microRNA**; it does not appear in major reviews or lists of functionally characterized microRNAs, nor is it described in disease, diagnostic, or therapeutic contexts[4][5]. - MIR6788 may be a predicted or uncharacterized entry in human microRNA databases such as miRBase, but its function and clinical relevance remain unestablished, which signals either insufficient characterization or potential misannotation. - If searching for a therapeutic target or well-characterized microRNA, MIR6788 is **not appropriate** based on available data. **Summary for structuring downstream data extraction:** - MIR6788 should be flagged as potentially **incorrect, missing, or insufficient** for use as a bona fide molecular target. - There is **no canonical disease, drug, or mechanism of action data** associated with this miRNA. - For microRNA research, consult entries with established biological roles and disease relevance.

Other names

hsa-mir-6788microRNA mir-6788MIR6788